A | Sample | Tested conc. (μg/ml) | Early apoptosis | Last apoptosis | Necrosis | |
---|---|---|---|---|---|---|
T2 (Treated cells) | 0.93 | 1.94 | 27 | 15.32 | ||
L3 (Treated cells) | 17.2 | 3.06 | 8.78 | 7.21 | ||
MDA-MB-231 cells (control) | 0 | 0.49 | 0.15 | 1.2 |
B | Sample | Tested conc. (μg/ml) | % G0–G1 | % S | % G2-M | % Pre G1 |
---|---|---|---|---|---|---|
T2 (Treated cells) | 0.93 | 55.03 | 41.92 | 3.05 | 44.26 | |
L3 (Treated cells) | 17.2 | 41.36 | 37.26 | 21.38 | 19.05 | |
MDA-MB-231 cells (control) | 0 | 46.04 | 41.26 | 12.7 | 1.84 |
C | Sample | Tested conc. (μg/ml) | ∆RFU | % of control | ||
---|---|---|---|---|---|---|
T2 (Treated cells) | 0.93 | 176,762.407 | 138.44 | |||
L3 (Treated cells) | 17.2 | 164,754 | 129.02 | |||
MDA-MB-231 cells (control) | 0 | 127,691.958 | 100 |